PR Newswire: Health http://www.prnewswire.co.uk/cgi/news/topic?id=699 Health Press releases distributed via PR Newswire. hourly 5 2005-01-01T00:00+00:00 PR Newswire Europe Ltd. Copyright © 1996-2008 PR Newswire Europe Ltd. All Rights Reserved. en-US 2009-01-06T17:00:02+00:00 PR Newswire: Health http://www.prnewswire.com/global/homepage/images/logo.gif http://www.prnewswire.co.uk/cgi/news/topic?id=699 Amira annonce la conclusion réussie d'études de toxicité conformément aux BPL pour un nouvel antagoniste du DP2. http://www.prnewswire.co.uk/cgi/news/release?id=245909 2009-01-06T16:57:00+0000 Kiadis Pharma ernennt Dr. Maarten Egeler, MD PhD zu ihrem Chief Medical Officer http://www.prnewswire.co.uk/cgi/news/release?id=245899 2009-01-06T15:39:00+0000 Kiadis Pharma nomme le Dr Maarten Egeler, Dr en médecine et Dr ès sciences, médecin en chef http://www.prnewswire.co.uk/cgi/news/release?id=245898 2009-01-06T15:36:00+0000 Amira anuncia la finalización de éxito de estudios de toxicidad GLP para un nuevo antagonista DP2 http://www.prnewswire.co.uk/cgi/news/release?id=245893 2009-01-06T15:00:00+0000 Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist. http://www.prnewswire.co.uk/cgi/news/release?id=245894 2009-01-06T15:00:00+0000 Kiadis Pharma nombra al doctor Maarten Egeler, MD PhD, director médico http://www.prnewswire.co.uk/cgi/news/release?id=245892 2009-01-06T14:39:00+0000 Eseguito presso importante centro oncologico milanese il primo trattamento radioterapico RapidArc in Italia http://www.prnewswire.co.uk/cgi/news/release?id=245880 2009-01-06T13:00:00+0000 Kiadis Pharma benoemt Dr. Maarten Egeler, MD PhD als Chief Medical Officer http://www.prnewswire.co.uk/cgi/news/release?id=245868 2009-01-06T09:39:00+0000 MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza http://www.prnewswire.co.uk/cgi/news/release?id=245866 2009-01-06T08:00:00+0000 Frost & Sullivan Lauds SonoScape's Outstanding Entrepreneurship http://www.prnewswire.co.uk/cgi/news/release?id=245862 2009-01-06T07:00:00+0000 ExonHit Therapeutics Renouvelle en L'Etendant sa Collaboration Strategique Avec Allergan http://www.prnewswire.co.uk/cgi/news/release?id=245861 2009-01-06T06:30:00+0000 New Year Quitters Urged to Invest in Their Family's Futures http://www.prnewswire.co.uk/cgi/news/release?id=245829 2009-01-05T13:51:00+0000 Study Shows Machine Perfusion Significantly Improves Transplant Results http://www.prnewswire.co.uk/cgi/news/release?id=245764 2008-12-31T22:00:00+0000 Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice http://www.prnewswire.co.uk/cgi/news/release?id=245766 2008-12-31T22:00:00+0000 Technique for Creating Authentic Rat Embryonic Stem Cells Published in Cell http://www.prnewswire.co.uk/cgi/news/release?id=245699 2008-12-29T12:00:00+0000 Serbia First in Europe to Participate in Phase 3 Clinical Trial of Lung Cancer Vaccine http://www.prnewswire.co.uk/cgi/news/release?id=245678 2008-12-29T07:00:00+0000 ExonHit Therapeutics Attribue Gratuitement des bons de Souscription D'Actions a Tous ses Actionnaires http://www.prnewswire.co.uk/cgi/news/release?id=245618 2008-12-23T13:27:00+0000 Sensible Christmas Snacking http://www.prnewswire.co.uk/cgi/news/release?id=245610 2008-12-23T11:00:00+0000 Elekta to Supply the Bank of Cyprus Oncology Centre With Advanced Radiation Therapy Treatment Systems for Cancer Care http://www.prnewswire.co.uk/cgi/news/release?id=245603 2008-12-23T07:00:00+0000 Glenmark Expects Launch of Crofelemer in ROW Countries (Developing Economies) by 2010 - Potential First-in-Class for HIV-Associated Diarrhea: Molecule Currently in Phase 3 Trials, Granted Fast Track Designation by US-FDA http://www.prnewswire.co.uk/cgi/news/release?id=245577 2008-12-22T12:27:00+0000 Search Recent Search PR Newswire's archived press releases from the last three working days. SEARCH http://199.230.26.105/fulltext